They seem to be a fairly low margin operation.Based on 1.2mt production.Revenue: 474 million randCost of sales: 408 million randI doubt Keaton have the +$50 margin ZYL should enjoy.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game